Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes

Published on May 9, 2025

A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.

Read Full Article (External Site)